£113,565.00 to £150,569.00 per year, £113565.00 - £150569.00 a year
Contract Type:
Permanent
Hours:
Full time
Disability Confident:
No
Closing Date:
21/06/2026
About this job
The successful applicant will share new referrals of adult neuro-oncology patients with colleagues.
The neuro-oncology new patient clinic takes place weekly at The Christie.
Referrals are divided equitably via a shared rotation of this clinic with approximately 250 new referrals per year.
They will have office accommodation provided within the clinical oncology department and 0.8 WTE secretarial/PA support.
The neuro-oncology team is active in research including imaging, basic science, radiotherapy and phase I, II and III clinical trials.
Prof McBain leads on trials of systemic therapy, Dr Whitfield has led on radiotherapy trials.
Neuro-oncology research is supported by 4 neuro-oncology research nurses and 4 Clinical Trials Administrators at The Christie, with additional staff at Salford.
Clinical trials are conducted via a dedicated once weekly neuro-oncology trials clinic and there are close links with the Early Phase Medicines team and the wider research infrastructure of the University of Manchester and MCRC. The successful applicant will help colleagues in supporting the conduct of clinical trials, with scope to develop this aspect of the role.
The successful applicant will be a core member of the pituitary MDT and will provide input into this patient group, alongside Clinical Oncologists Dr Claire Barker and Dr Jenny King, Endocrinologist Dr Claire Higham and other colleagues.
They will also have expertise in, and work with colleagues to deliver, the stereotactic radiosurgery service.
This is Tier 1 and Tier 2 provision, treating brain metastases, meningiomas, vestibular schwannomas and pituitary tumours.
The successful applicant will work with Prof McBain to provide cross-cover for the oncology aspect of the NF2 service (MDT and systemic therapy delivery) and the skull base MDT and service.
Full support and training will be given for this aspect of the role.
A further aspect of this post will be to share responsibility for the clinical leadership and development of the neuro-oncology late effects service, working closely with and supported by other colleagues including Dr Claire Higham, Consultant Endocrinologist, Dr Martin McCabe, TYA Medical Oncologist and Dr Anthony Penn, paediatric Medical Oncologist.
The late effects clinic population comprises patients who were treated as children or young adults.
Late effects clinic review provides assessment and management of the late effects of treatment.
The importance and prominence of this aspect of oncology care is being increasingly recognised nationally and internationally; it is a key component of The Christie clinical and research strategy.
There is much scope to develop this aspect of the role via research and publication, and in collaboration with the Proton service and with colleagues locally and internationally.
Job Plan TimetableThe timetable below is indicative and will be confirmed on commencement in post.
It is the requirement of the Trust that all new consultant colleagues must have 0.25 SPAs within their job plan to support Trust appraisal and supervision requirements.
This can either be as appraiser or a supervisor for medical staff or Advanced Clinical Practitioners (ACP). Monday Tuesday Wednesday Thursday Friday AM SPA (1PA) Neuro-oncology MDT (1PA) Outpatient clinic (review and chemo) (Christie) (1PA) Pituitary MDT 0800-1000 (alternate weeks) (at Salford or on Teams (0.25 PA) Research clinic (alt weeks) (0.5 PA) Admin (0.25 PA) Late effects clinic / SRS clinic / skull base MDT (by rotation) (1 PA) PM SPA (1 PA) On-treatment reviews / planning (1PA) Admin (0.5 PA) SPA ( 0.5 PA) New patient clinic (Christie) (1PA) NB This timetable is indicative Job Plan PA Summary Total PAs Direct Clinical Care (DCC)
5.5 Planning
1.0 MDT
2.25 Admin
1.0 Supporting Professional Activities (SPA) (including
1.5 core SPA)
2.5 Supervision role (minimum 0.25 must be allocated) 0.25 Research (additional programmed Activity Fixed term) 5 year
1.0 Total Programmed Activities (PAs) 8 Research APA is not permanently funded and will be confirmed following the outcome of the recruitment in line with job planning policy.
Contact Details:
Career Choices Dewis Gyrfa Ltd Recruitment Team
